Significant improvement on MitoQ
- Condition
- ME/CFS
- At worst
- Moderate (mostly housebound)
- Ill for
- unspecified
- Published
- Jan 2015
Summary
MitoQ, taken as 5mg twice daily for 6 days, sharply cut this person's fatigue within hours of the first dose. Illness duration before starting is not stated. Fatigue levels dropped and post-exertional malaise decreased over the 6-day trial, with skin quality also improving. The post ends at day 6 with no longer-term follow-up reported, so it is unclear whether the benefit was sustained or required ongoing dosing.
Similar stories
-
Did MitoQ Mend Us? A Fibromyalgia and Chronic Fatigue Syndrome (ME/CFS) CoQ10 Trial
MitoQ at 10mg per day was, in this ME/CFS patient's words, "extremely helpful" and, she said, the first drug to keep her from crashing. Illness duration before the trial is not stated. She enrolled in a non-placebo-controlled arm of a formal MitoQ trial but…
-
Did MitoQ Mend Us? A Fibromyalgia and Chronic Fatigue Syndrome (ME/CFS) CoQ10 Trial
MitoQ caused severe insomnia in this ME/CFS patient (diagnosed at OMI) after a single 10mg dose, and moderate-to-severe insomnia again when a lower 5mg dose was tried separately. No fatigue or functional benefit is reported from either trial. The person…
-
Anybody taking MitoQ?
MitoQ was taken orally for about 4 to 5 months, with no dose specified in the post. Illness duration before treatment is not stated. The person reports it simply "didn't seem to help" and was expensive, so they discontinued it. They switched back to regular…